Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR
The FASEB Journal · 2023
DOI: 10.1096/fj.202200400rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2023. Verfasst von Jun Ren und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Affiliated Shanghai Fifth People's Hospital, Fudan University, Shanghai, People's Republic of China. Hauptthemen laut MEDLINE: Annexin A1, Stomach Neoplasms. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Resistance to oxaliplatin (OXA) is a major cause of recurrence in gastric cancer (GC) patients. Autophagy is an important factor ensuring the survival of cancer cells under chemotherapeutic stress. We aimed to investigate the role of OXA‐related genes in autophagy and chemoresistance of gastric cancer cells. We established OXA‐resistant gastric cancer cells and used RNA‐seq to profile gene expression within OXA‐resistant GC and corresponding parental cells. Immunohistochemistry and RT‐qPCR was performed to detect gene expression in tissues of two cohorts of GC patients who received OXA‐based chemotherapy. The chemoresistant effects of the gene were assessed by cell viability, apoptosis, and autophagy assays. The effects of the gene on autophagy were assessed with mRFP‐GFP‐LC3 and Western blotting (WB). Gene set enrichment analysis (GSEA) and WB were performed to detect the activity of PI3K/AKT/mTOR signaling under the regulation of the gene. The OXA‐resistant property of GC cells is related to their enhanced autophagic activity. Based on RNA‐seq profiling, ANXA1 was selected as a candidate, as it was upregulated significantly in OXA‐resistant cells. Furthermore, we found that higher ANXA1 expression before chemotherapy was associated with subsequent development of resistance to oxaliplatin, and overexpression of ANXA1 promoted the resistance of gastric cancer cells to oxaliplatin. So, it may serve as a key regulator in GC chemo‐resistance knockdown of ANXA1, via inhibiting autophagy, enhancing the sensitivity of OXA‐resistant GC cells to OXA in vitro and in vivo. Mechanically, we identified that PI3K/AKT/mTOR signaling pathway was activated in the ANXA1 stable knockdown AGS/OXA cells, which leads to the suppression of autophagy. ANXA1 functions as a chemoresistant gene in GC cells by targeting the PI3K/AKT/mTOR signaling pathway and might be a prognostic predictor for GC patients who receive OXA‐based chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Affiliated Shanghai Fifth People's Hospital, Fudan University, Shanghai, People's Republic of China.
- Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou, People's Republic of China.
- General Surgery Institute of Yangzhou, Yangzhou University, Yangzhou, People's Republic of China.
ORCID-Profile: Jun Ren, Gengming Niu, Chongwei Ke
Zitieren
APA
Ren, J., Hu, Z., Niu, G., Xia, J., Wang, X., Hong, R., Gu, J., Wang, D., & Ke, C. (2023). Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR. The FASEB Journal. https://doi.org/10.1096/fj.202200400rr
Vancouver
Ren J, Hu Z, Niu G, Xia J, Wang X, Hong R, et al. Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR. The FASEB Journal. 2023. doi:10.1096/fj.202200400rr
BibTeX
@article{Ren2023,
author = {Ren, Jun and Hu, Zhiqing and Niu, Gengming and Xia, Jie and Wang, Xing and Hong, Runqi and Gu, Jiawei and Wang, Daorong and Ke, Chongwei},
title = {Annexin A1 induces oxaliplatin resistance of gastric cancer through autophagy by targeting PI3K/AKT/mTOR},
journal = {The FASEB Journal},
year = {2023},
doi = {10.1096/fj.202200400rr}
}
EUVIMED